S26G (p.Ser26Gly) variant of ABL2 (Tyrosine-protein kinase ABL2)
S26G (p.Ser26Gly) in ABL2 (Tyrosine-protein kinase ABL2) is a missense change. The available variant effect predictions contribute to a CATVariant prioritization score of 0.22 / 1. The record also includes population frequency data.
S26G (p.Ser26Gly) variant details
- p.Ser26Gly
- TOPMed rs1663417819
- Missense
- Variant Prioritization Score for Impact Estimate 0.222
- REVEL 0.14
- CADD 18.10
- PolyPhen-2 0.00
- SIFT 0.76
- Population evidence available